IMMP
IMMUTEP Ltd
NASDAQ · Healthcare · Biotechnology · AU
$0.29
−9.21%Margins
Gross margin
-186.5%
EBITDA margin
-500.7%
EBIT margin
-513.9%
Net margin
-479.2%
FCF margin
-344.5%
-129.7%
Return on equity
-95.8%
Return on assets
-136.7%
Return on invested capital
0.14x
Asset turnover
-$40.7M
Cash from operations
$0.33
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026